Tag Archives: Hereditary angioedema

August, 2018

June, 2018

July, 2017

June, 2017

May, 2017

March, 2017

August, 2016

July, 2016

November, 2015

  • 2 November

    Shire to Acquire Dyax for up to $6.5 Billion

    Shire plc (LSE: SHP, NASDAQ: SHPG) and Dyax Corp. (NASDAQ: DYAX) today announced that Shire will acquire Dyax for $37.30 in cash per Dyax share, for aggregate upfront consideration of approximately $5.9 billion. Dyax shareholders may receive additional value through a non-tradable contingent value right (CVR) that will pay $4.00 …

April, 2015